Skip to main content
Log in

Major Liver Resection for Large and Locally Advanced Hepatocellular Carcinoma

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Optimal management of large and locally advanced hepatocellular carcinoma (HCC) remains a clinical challenge especially in patients with chronic liver disease (CLD). We present our experience of major liver resection for large and locally advanced HCC. Prospectively collected data of patients with large and locally advanced HCC who underwent major liver resection between March 2011 and May 2015. The outcome measures of interest were the characteristics of tumor, surgical outcome, and overall as well as disease-free survival. Eighteen patients (14 male) with median age of 59 years (20 to 73 years) with good performance status underwent resection. Fifteen patients were in Child Pugh class A and three in class B. On contrast-enhanced computed tomography (CECT) scan, four patients had lobar/segmental portal vein involvement, two patients had bilobar disease, and one had biliary obstruction. Seven patients underwent extended resection (>5 segments), five right hepatectomy, two modified right hepatectomy, one modified right hepatectomy with wedge resection of segment six, two left hepatectomy, and one left lateral sectionectomy. On histopathology, 12 were solitary and six were multiple, the median tumor diameter was 9 cm (5–18 cm). All 18 patients had R0 resection. Eight patients had cirrhosis, six had fibrosis, and four had chronic hepatitis. Vascular invasion was noticed in 12 and out of these, six had large-vessel embolization. Morbidity according to Clavien-Dindo class was grades 1–11, grades 2–5, grade 3B-1, and grades 5–1. After a median follow-up of 32 months (6–54 months), the overall survival at 1 and 3 years was 83 and 54 %, respectively. The disease-free survival at 1 and 3 years was 75 and 54 % respectively. In carefully selected patients with large and locally advanced HCC, acceptable perioperative and medium term outcomes can be achieved with major liver resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AFP:

Alpha-fetoprotein

BCLC:

Barcelona Clinic Liver Cancer

CTP:

Child-Turcotte-Pugh

CLD:

Chronic liver disease

CECT:

Contrast-enhanced computerized tomography

ECOG:

Eastern Cooperative Oncology Group

HCC:

Hepatocellular carcinoma

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917

    Article  CAS  PubMed  Google Scholar 

  2. Sherman M (2010) Epidemiology of hepatocellular carcinoma. Oncology 78:7–10

    Article  PubMed  Google Scholar 

  3. Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338

    Article  CAS  PubMed  Google Scholar 

  4. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the liver. J Hepatol 35:421–430

    Article  CAS  PubMed  Google Scholar 

  5. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang JH, Changchien CS, Hu TH, Lee CM, Kee KM, Lin CY, et al. (2008) The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for Hepatocellular carcinoma—survival analysis of 3892 patients. Eur J Cancer 44:1000–1006

    Article  PubMed  Google Scholar 

  7. Pascual S, Zapater P, Such J, García-Herola A, Sempere L, Irurzun J, et al. (2006) Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver Int 26:673–679

    Article  PubMed  Google Scholar 

  8. Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, et al. (2006) Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol 44:723–731

    Article  PubMed  Google Scholar 

  9. Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, et al. (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41:707–716

    Article  PubMed  Google Scholar 

  10. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, et al. (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:364–373

    Article  PubMed  Google Scholar 

  11. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, et al. (2005) Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450–457

    Article  PubMed  Google Scholar 

  12. Chirica M, Scatton O, Massault PP, Aloia T, Randone B, Dousset B, et al. (2008) Treatment of stage IVA hepatocellular carcinoma. Should we reappraise the role of surgery? Arch Surg 143:538–543

    Article  PubMed  Google Scholar 

  13. Torzilli G, Donadon M, Marconi M, Palmisano A, Del Fabbro D, Spinelli A, et al. (2008) Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona clinic liver cancer classification: results of a prospective analysis. Arch Surg 143:1082–1090

    Article  PubMed  Google Scholar 

  14. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908–1916

    Article  PubMed  Google Scholar 

  15. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, et al. (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC east-west study group. Ann Surg 257:929–937

    Article  PubMed  Google Scholar 

  16. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229(6):790–799 discussion 799-800

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  18. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503

    Article  CAS  PubMed  Google Scholar 

  19. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  20. Choi SB, Kim HJ, Song TJ, Ahn HS, Choi SY (2014) Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 21:639–647

    Article  PubMed  Google Scholar 

  21. Tang YH, Zhu WJ, Wen TF (2014) Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis. Asian Pac J Cancer Prev 15(4):1649–1654

    Article  PubMed  Google Scholar 

  22. Poon RTP, Fan ST, Wong J (2002) Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592–602

    Article  PubMed  Google Scholar 

  23. Yeh CN, Lee WC, Chen MF (2003) Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang gung memorial hospital. Ann Surg Oncol 10:1070–1076

    Article  PubMed  Google Scholar 

  24. Shrager B, Jibara GA, Tabrizian P, Schwartz ME, Labow DM, Hiotis S (2013) Resection of large hepatocellular carcinoma (>10 cm): a unique western perspective. J Surg Oncol 107:111–117

    Article  PubMed  Google Scholar 

  25. Yang LY, Fang F, Ou DP, Wu W, Zeng ZJ, Wu F (2009) Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg 249:118–123

    Article  PubMed  Google Scholar 

  26. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS (2007) Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 94:320–326

    Article  CAS  PubMed  Google Scholar 

  27. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC (2007) Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 14:2817–2823

    Article  PubMed  Google Scholar 

  28. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243(2):229–235

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK (2005) Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 92:348–355

    Article  PubMed  Google Scholar 

  30. Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. doi:10.1053/j.gastro.2015.12.041

    PubMed  Google Scholar 

  31. Sharr WW, Chan SC, CM L (2014) Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation. Transplantation 97(Suppl 8):S10–S17

    Article  PubMed  Google Scholar 

  32. Parikh ND, Waljee AK, Singal AG (2015) Downstaging hepatocellular carcinoma: a systematic review and pooled analysis. Liver Transpl 21(9):1142–1152

    Article  PubMed  Google Scholar 

  33. Bhangui P, Allard MA, Vibert E, Cherqui D, Pelletier G, Cunha AS, et al. (2016) Salvage versus primary liver transplantation for early hepatocellular carcinoma: do both strategies yield similar outcomes? Ann Surg 264(1):155–163

    Article  PubMed  Google Scholar 

  34. Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, et al. (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62(2):440–451

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Viniyendra Pamecha.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pamecha, V., Sasturkar, S.V., Sinha, P.K. et al. Major Liver Resection for Large and Locally Advanced Hepatocellular Carcinoma. Indian J Surg 79, 326–331 (2017). https://doi.org/10.1007/s12262-016-1545-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-016-1545-3

Keywords

Navigation